Call Our Helpline
This is a twelve month operational research study and aims evaluate the contraceptive effectiveness, safety and acceptability of Femplant® (a 4-year contraceptive implant) during the first year of its use in public and private sector health services facilities of Sindh and Punjab in Pakistan. The study is sponsored by FHI360-USA with the financial support of USAID-USA. MSI UK is providing technical support to this study. This is a multi-country study and being simultaneously implemented in six developing countries. In Pakistan, this study is jointly implemented by Marie Stopes Society (MSS) and Population Welfare Department of Sindh. The study has a full approval from National Bioethics Committee (NBC) Pakistan (reference number: 4-8711/NBC-65/RDC/ 386 (08-Aug-2011).) and Institutional Review Board (IRB) of FHI. The study will comply with all of the applicable Marie Stopes International (MSI) and MSS standard operating procedures and the requirements of the study protocol, NBC and FHI IRB. The time duration for the study is October, 2011-December, 2012.
The present study will provide data on post-implant pregnancy, adverse experience, insertion/removal complications, method continuation and level of women’s satisfaction with services. Further, the findings of this study will contribute to the body of knowledge on the acceptance of the Femplant in Pakistan and help provide timely recommendations for the successful introduction of this new long term method in the country.